Skip to main content

. 1975 Oct 11;4(5988):85. doi: 10.1136/bmj.4.5988.85

Increase in serum cholesterol during phenytoin treatment.

R Pelkonen, R Fogelholm, E A Nikkilä

PMCID: PMC1674895 PMID: 1182477

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Jones A. L., Armstrong D. T. Increased cholesterol biosynthesis following phenobarbital induced hypertrophy of agranular endoplasmic reticulum in liver. Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):1136–1139. doi: 10.3181/00379727-119-30396. [DOI] [PubMed] [Google Scholar]
Kizer J. S., Vargas-Gordon M., Brendel K., Bressler R. The in vitro inhibition of insulin secretion by diphenylhydantoin. J Clin Invest. 1970 Oct;49(10):1942–1948. doi: 10.1172/JCI106413. [DOI] [PMC free article] [PubMed] [Google Scholar]
Redinger R. N., Small D. M. Primate biliary physiology. 8. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition. J Clin Invest. 1973 Jan;52(1):161–172. doi: 10.1172/JCI107160. [DOI] [PMC free article] [PubMed] [Google Scholar]
Stambaugh J. E., Tucker D. C. Effect of diphenylhydantoin on glucose tolerance in patients with hypoglycemia. Diabetes. 1974 Aug;23(8):679–683. doi: 10.2337/diab.23.8.679. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES